Acta Scientific Pharmaceutical Sciences

Research Article Volume 9 Issue 2

Creon 10k vs Pancrelip 10k: A Comparative In vitro Analysis of Lipase Activity of Pancreatin EC Pellets

Umang Budhraja, Komal Kamble, Manish Sharma and Anamika Mishra*

Umang Global Pvt Ltd., Mumbai, Maharashtra, India

*Corresponding Author: Anamika Mishra, Umang Global Pvt Ltd., Mumbai, Maharashtra, India.

Received: January 15, 2025; Published: January 21, 2025

Abstract

Pancreatic enzyme supplements are essential in the treatment of exocrine pancreatic insufficiency (EPI), which is characterized by the pancreas's failure to release enzymes and bicarbonate necessary for effective digestion leading to impaired digestion and nu trient absorption. However, the efficacy of EC Pancreatic pellets are dependent on enzymatic activity and pH-Dependent dissolution. This study aimed to compares the enzymatic activities and in vitro dissolution at different phosphate buffer range from pH 1.2 to 7.4 of two different EC coated Pancreatic pellets i.e. Creon10k (Abbot India Pvt Ltd) and Pancrelip 10k (Umang Global Pvt Ltd). Creon 10k, a marketed formulation was compared with Pancrelip 10k which is manufactured by Umang Global Pvt Ltd. All these study methods are performed as described in the US Pharmacopeia. Studies have shown that Pancrelip 10k, when compared to Creon 10k, is a suitable substitute for treating EPI, as it shows a similar enzymatic activity for Amylase, Lipase and Protease as well as in vitro dissolution for Lipase release.

Keywords:Exocrine Pancreatic Insufficiency; EC Pancreatin Pellets; Comparison Study; Enzymatic Activity; In Vitro Dissolution; Lipase Activity

References

  1. Diéguez-Castillo Carmelo., et al. “State of the Art in Exocrine Pancreatic Insufficiency”. Medicina10 (2020): 523.
  2. Bhattacharyya BK., et al. “Treatment of Pancreatic Exocrine Insufficiency with Enteric Coated Pancreatin Formulations: An Overview”. International Journal of Pharmaceutical Sciences and Nanotechnology3 (2013): 2125-2130.
  3. D’Haese Jan G., et al. “Pancreatic Enzyme Replacement Therapy in Patients with Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis”. Pancreas 6 (2014): 834-841.
  4. Whitcomb David C., et al. “AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review”. Gastroenterology5 (2023): 1292-1301.
  5. “A consensus statement on the diagnosis and treatment of pancreatic exocrine insufficiency after pancreatic surgery”. PubMed9 (2018): 641-645.
  6. , et al. “Clinical Profile and Management of Pancreatic Exocrine Insufficiency in Patients with Chronic Pancreatitis in India”. Journal of the Association of Physicians of India 66.12 (2018): 33-40.
  7. Domínguez-Muñoz J Enrique. “Pancreatic exocrine insufficiency: Diagnosis and treatment”. Journal of Gastroenterology and Hepatology2 (2011): 12-16.
  8. Regan Patrick T and Eugene P DiMagno. “Exocrine pancreatic insufficiency in celiac sprue: A cause of treatment failure”. Gastroenterology3 (1980): 484-487.
  9. Aloulou A., et al. “In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability”. Alimentary Pharmacology and Therapeutics3 (2007): 283-292.
  10. Guarner L., et al. “Fate of oral enzymes in pancreatic insufficiency”. Gut5 (1993): 708-712.
  11. Mössner Joachim and Volker Keim. “Pancreatic Enzyme Therapy”. Deutsches Ärzteblatt International 108 (2011): 578-582.
  12. Vujasinovic Miroslav., et al. "Pancreatic Exocrine Insufficiency in Pancreatic Cancer." Nutrients3 (2017): 183.
  13. Löhr Johannes-Matthias., et al. “Properties of different pancreatin preparations used in pancreatic exocrine insufficiency”. European Journal of Gastroenterology and Hepatology9 (2009): 1024-1031.
  14. "Exocrine Pancreatic Insufficiency Drug Products". Register 28 Apr. (2004).
  15. Gan Can., et al. "Efficacy and safety of pancreatic enzyme replacement therapy on exocrine pancreatic insufficiency: a meta-analysis". Oncotarget55 (2017): 94920.

Citation

Citation: Anamika Mishra., et al. “Creon 10k vs Pancrelip 10k: A Comparative In vitro Analysis of Lipase Activity of Pancreatin EC Pellets". Acta Scientific Pharmaceutical Sciences 9.2 (2025): 02-07.

Copyright

Copyright: © 2025 Anamika Mishra., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US